Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 30, 2012

View Archived Issues

U.S. university researchers disclose novel beta-amyloid production inhibitors

Pierre Fabre discloses new monoclonal antibodies for cancer

Novartis reflects on accomplishments of 2011

Novel phosphodiesterase 10A inhibitors prepared by Lundbeck

Merck KGaA patents new TGF-beta receptor type-1 inhibitors

Janssen Pharmaceutica synthesizes novel beta-secretase 1 inhibitors

Scientists at Cellzome patent novel TYK2 inhibitors

Histone deacetylase inhibitors may have potential in treating Gaucher's disease

Experiments delineate antiseizure activity of valpromide homolog

GenVec extends licensing and collaboration agreement with Novartis

Swissmedic grants marketing authorization for transdermal estradiol spray

Amgen enters definitive merger agreement

Cancer Research UK begins study of AT-9283

Indication for Gadovist 1.0 is expanded

FDA accepts bosutinib NDA for review

Infinity Pharmaceuticals completes preliminary analysis of saridegib/gemcitabine combination study

FDA approves axitinib for advanced renal cell carcinoma

Cell Therapeutics withdraws Pixuvri NDA

FDA approves first-ever once-weekly treatment for type 2 diabetes

European Commission requests further information in Glybera review

IDMC reviews Ziopharm's study of palifosfamide in metastatic soft tissue sarcoma

Amgen offers pipeline update for 2011

MT-110 shows promise in models of pancreatic cancer

Overseas trials begin for Pro-Rvlysin prostate cancer treatment

Navidea Biopharmaceuticals enters into agreement for Parkinson's disease imaging agent

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 20, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...